DAIC

MARCH 31, 2025

Abelacimab is currently in Phase 3 development with the lead indication for the prevention of stroke and systemic embolism in patients with atrial fibrillation (LILAC-TIMI 76), in addition to two studies in patients with cancer-associated thrombosis (ASTER and MAGNOLIA). Data from these trials are expected in the second half of 2026.

Atrial Fibrillation 52

Atrial Fibrillation BMI General Cardiology Thrombosis 52

Frontiers in Cardiovascular Medicine

DECEMBER 5, 2024

Age, proximal and distal deep vein thrombosis (DVT) vs. distal DVT, active cancer, history of long-term immobilization, VTE was detected in the intensive care unit, active/recurrent bleeding, IVC thrombosis, and history of venous thromboembolism were independent predictive risk factors for non-retrieval of filters.

Thrombosis 40

Thrombosis Cancer Risk Factors Research 40

Frontiers in Cardiovascular Medicine

JANUARY 4, 2024

Background Left atrial (LA) hemodynamics after lung lobectomies with pulmonary vein (PV) resection is widely understood to be a risk factor for LA thrombosis. Methods The computational simulations of LA blood flow were conducted on the basis of four-dimensional computed tomography images of four lung cancer patients prior to lobectomies.

Pulmonary 45

Pulmonary Thrombosis Cancer Risk Factors 45

Stroke Journal

FEBRUARY 1, 2024

Background and Objectives:Understanding the mechanisms of thrombosis is crucial for the future advancement in treating ischemic stroke. After adjusting for potential confounders including posterior circulation occlusion, serum hemoglobin levels, serum albumin levels, and the presence of active cancer (all p<0.05

Thrombosis 40

Thrombosis Stroke Strokes Cancer 40

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Introduction The guidelines' recommendations for anticoagulation in cancer patients with catheter-related thrombosis are unclear. The aim of this systematic review was to assess anticoagulation management in cancer patients with catheter-related thrombosis (CRT) based on previously published studies.

Thrombosis 69

Thrombosis Cancer Outcomes 69

The New England Journal of Medicine

MARCH 28, 2025

Venous thromboembolism is a common complication of cancer and its treatments, and the incidence of recurrent thrombosis, serious bleeding, and death is higher among patients with this condition than in the general population. More than 20 years have passed since Lee et al.1 1 reported the results of the.

Cancer 51

Cancer Thrombosis 51

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Background Stent thrombosis (ST) is an uncommon but serious complication of stent implantation. age, sex, ACS presentation, history of hypertension, smoking, diabetes, prior myocardial infarction (MI), heart failure, prior ischemic stroke, and cancer], laboratory tests [i.e.,

Stents 64

Stents Stent Thrombosis Myocardial Infarction 64

Frontiers in Cardiovascular Medicine

FEBRUARY 5, 2024

Phlegmasia cerulea dolens (PCD) is a rare yet severe complication of deep vein thrombosis (DVT), characterized by a high amputation rate and mortality. Early diagnosis and treatment are crucial in managing this condition. PCD predominantly affects the lower extremities rather than the upper extremities.

Embolism 64

Embolism Cancer ICU Thrombosis 64

Stroke Journal

OCTOBER 27, 2023

The composition of thrombi may reflect the mechanism of thrombosis, aiding the determination of the treatment strategy. Platelet composition was significantly higher in the cancer group than in the control group (median [interquartile range], 51.3% [28.0%–61.4%] 61.4%] versus 9.5% [4.8%–14.0%];P<0.001). 14.0%];P<0.001).

Cancer 40

Cancer Stroke Strokes Thrombosis 40

Stroke Journal

FEBRUARY 1, 2024

Background and Purpose:Cancer increases the risk for acute ischemic stroke (AIS) and deep venous thrombosis. The role of paradoxical embolization as a stroke etiology in patients with cancer is uncertain. Our study investigated the relationship between cancer-related stroke and the presence of a patent foramen ovale (PFO).Methods:We

Cancer 40

Cancer Stroke Strokes Thrombosis 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionCerebral venous sinus thrombosis (CVST) is a rare form of stroke that usually affects young females especially during pregnancy and the postpartum period. The symptoms of cerebral venous sinus thrombosis can vary depending on the location and extent of the clot.

Thrombosis 40

Thrombosis Outcomes Cancer Risk Factors 40

Stroke Journal

JANUARY 30, 2025

Introduction:Acute ischemic stroke (AIS) patients are prone to medical complications such as acute kidney injury (AKI), acute myocardial infarction (AMI), deep vein thrombosis (DVT), gastrointestinal bleeding (GIB), pneumonia, pulmonary embolism (PE), sepsis, and urinary tract infection (UTI).

Cancer 40

Cancer Stroke Strokes Myocardial Infarction 40

Heart 2023 Conference

APRIL 20, 2022

Harvard University Heart Letter) A clinical polygenic risk score test for diseases ranging from atrial fibrillation (AFib) to breast cancer was piloted by scientists. Avocado consumption of at least two servings per week is linked to a lower risk of cardiovascular disease.

Pulmonary 52

Pulmonary Hypertension AFIB COVID-19 52

Stroke Journal

FEBRUARY 1, 2024

Introduction:Active cancer is a known risk factor for cerebral venous thrombosis (CVT), but it is unknown whether CVT is also associated with occult cancer. Patients with a history of cancer and patients diagnosed with cancer during admission for the index CVT were excluded. after 10 years. at 1 year and 1.4 [1.1-1.7]

Cancer 40

Cancer Thrombosis Risk Factors Hospital 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionCerebral Venous Thrombosis (CVT) is a rare cerebrovascular condition causing death or functional dependency in 10‐15%. 0.48, p=0.001), CNS cancer (OR: 0.24, 95% CI: 0.06‐0.93, 0.93, p=0.039), other types of cancer (OR: 0.47, 95% CI: 0.32‐0.69, 2.67, p<0.001), seizure (OR: 1.54, 95% CI: 1.09‐2.16,

Thrombosis 40

Thrombosis Cancer Inpatient Hospital 40

Frontiers in Cardiovascular Medicine

MARCH 30, 2025

Subsequent investigations revealed pulmonary embolism, deep vein thrombosis, and imaging findings suggestive of pancreatic cancer. Following PCI, she was treated with optimal medical therapy, including dual antiplatelet therapy. Anticoagulation therapy was initiated to manage the VTE.

Myocardial Infarction 52

Myocardial Infarction Embolism Cancer Pulmonary 52

AMS Cardiology

MARCH 20, 2025

Deep Vein Thrombosis (DVT) : A blood clot occurring in a deep vein. Causes include infection, malignancy, surgery, scar tissue formation, trauma, deep vein thrombosis (DVT), radiation or other cancer treatment. Damaged valves within the veins cause this.

Vascular Care 52

Vascular Care Blood Clot Aneurysm Peripheral Arterial Disease 52